DeepMed Research

Bausch & Lomb Incorporated

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1992-10-08

Employees: -

Market Cap: -

Website

Clinical Trials

A Study to Evaluate Early Treatment Outcomes With Miebo™ in Subjects With Dry Eye Disease

Phase 4

Completed

Conditions: Dry Eye

Interventions: Drug: Miebo

First Posted Date: 2024-03-13

Last Posted Date: 2024-06-21

Lead Sponsor: Bausch & Lomb Incorporated

Target Recruit Count: 99

Registration Number: NCT06309953

Locations: 🇺🇸
Site 203, Pittsburg, Kansas, United States
🇺🇸
Site 202, Kansas City, Missouri, United States
🇺🇸
Site 204, Stillwater, Minnesota, United States

and more 2 locations

A Study to Evaluate the Safety and Efficacy of the Bausch + Lomb Myopia Control Lens for the Correction of Myopic Ametropia and Slowing the Progression of Myopia in Children

Not Applicable

Recruiting

Conditions: Myopia

Interventions: Device: Bausch + Lomb (kalifilcon A) Myopia Control Soft (Hydrophilic)
Device: CooperVision MiSight (omafilcon A/60%) Myopia Control one day Soft Contact Lens

First Posted Date: 2024-03-12

Last Posted Date: 2024-05-23

Lead Sponsor: Bausch & Lomb Incorporated

Target Recruit Count: 418

Registration Number: NCT06305663

Locations: 🇨🇳
Site 103, Chengdu, Sichaun Province, China
🇨🇳
Site 110, Wuhan, Hubei, China
🇨🇳
Site 105, Beijing, Beijing, China

and more 8 locations

Kalifilcon A Toric Compared to Commercially Available Lenses

Not Applicable

Completed

Conditions: Astigmatism

Interventions: Device: Precision1 for Astigmatism
Device: Kalifilcon Toric Lens
Device: MyDay Toric
Device: Total1 for Astigmatism

First Posted Date: 2023-10-25

Last Posted Date: 2024-12-10

Lead Sponsor: Bausch & Lomb Incorporated

Target Recruit Count: 30

Registration Number: NCT06098937

Locations: 🇺🇸
Bausch & Lomb, Incorporated, Rochester, New York, United States

Orientation Characteristics of Kalifilcon A Daily Disposable Toric Contact Lenses Compared to Acuvue Oasys 1-Day for Astigmatism Contact Lenses

Not Applicable

Completed

Conditions: Astigmatism

Interventions: Device: Acuvue Oasys 1-Day for Astigmatism
Device: Kalifilcon a Contact Lens for Astigmatism

First Posted Date: 2023-10-06

Last Posted Date: 2023-10-06

Lead Sponsor: Bausch & Lomb Incorporated

Target Recruit Count: 30

Registration Number: NCT06069609

Locations: 🇺🇸
Bausch & Lomb, Incorporated, Rochester, New York, United States

IC-8 Apthera IOL New Enrollment Post Approval Study

Recruiting

Conditions: Cataract
Posterior Capsule Opacification
Presbyopia

First Posted Date: 2023-09-29

Last Posted Date: 2025-01-17

Lead Sponsor: Bausch & Lomb Incorporated

Target Recruit Count: 435

Registration Number: NCT06060041

Locations: 🇺🇸
Trinity Research Group, LLC, Dothan, Alabama, United States
🇺🇸
Feinerman Vision Center, Newport Beach, California, United States
🇺🇸
Argus Research Center, Cape Coral, Florida, United States

and more 9 locations

1-Week Dispensing Evaluation of REVIVE™ Toric Soft Contact Lenses

Not Applicable

Completed

Conditions: Refractive Ametropia

Interventions: Device: REVIVE Contact Lens

First Posted Date: 2023-09-26

Last Posted Date: 2024-01-05

Lead Sponsor: Bausch & Lomb Incorporated

Target Recruit Count: 26

Registration Number: NCT06053736

Locations: 🇺🇸
Bausch & Lomb, Incorporated, Rochester, New York, United States

Study of Safety and Effectiveness of the Boston Orthokeratology Shaping Lens in the Arise Orthokeratology Lens

Not Applicable

Completed

Conditions: Astigmatism

Interventions: Device: orthokeratology lens

First Posted Date: 2023-08-09

Last Posted Date: 2024-08-26

Lead Sponsor: Bausch & Lomb Incorporated

Target Recruit Count: 90

Registration Number: NCT05984290

Locations: 🇺🇸
Optometric Physicians of Middle Tennessee, Nashville, Tennessee, United States
🇺🇸
Levenson Eye Associates, Jacksonville, Florida, United States
🇺🇸
Cornea and Contact Lens Institute of Minnesota, Edina, Minnesota, United States

and more 3 locations

Evaluation of the Safety and Pharmacokinetics of Brimonidine Tartrate 0.025%/Ketotifen Fumarate 0.035% Combination Ophthalmic Solution

Completed

Conditions: Allergic Conjunctivitis

First Posted Date: 2023-04-18

Last Posted Date: 2024-06-12

Lead Sponsor: Bausch & Lomb Incorporated

Target Recruit Count: 511

Registration Number: NCT05815758

Locations: 🇺🇸
104- Arizona Eye Center, Chandler, Arizona, United States
🇺🇸
103- Seidenberg Protzko Eye Associates, Havre De Grace, Maryland, United States
🇺🇸
105- NC Eye Associates, Apex, North Carolina, United States

and more 4 locations

Evaluation of Visual Acuity of the Envista One-piece Acrylic Toric IOL MX60ET

Completed

Conditions: Astigmatism

First Posted Date: 2023-02-22

Last Posted Date: 2023-02-22

Lead Sponsor: Bausch & Lomb Incorporated

Target Recruit Count: 100

Registration Number: NCT05739656

Locations: 🇺🇸
Jeffrey Whitman, MD, Dallas, Texas, United States

Effects of NOV03 on the Tear Film

Phase 4

Completed

Conditions: Dry Eye Disease (DED)

Interventions: Drug: instillation of NOV03

First Posted Date: 2023-02-13

Last Posted Date: 2024-03-12

Lead Sponsor: Bausch & Lomb Incorporated

Target Recruit Count: 27

Registration Number: NCT05723770

Locations: 🇺🇸
Site 101, Miami, Florida, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy